NAV
$27.33
AUM
$53.5M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.75% | +1.59% | +4.92% | +6.73% | - | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | IBM | International Business Machines Corp | 4.28% |
| 2 | MRK | Merck & Co Inc | 3.90% |
| 3 | EOG | EOG Resources Inc | 3.79% |
| 4 | COP | ConocoPhillips | 3.77% |
| 5 | QCOM | Qualcomm Inc | 3.73% |
| 6 | UNH | UnitedHealth Group Inc | 3.70% |
| 7 | VICI | VICI Properties Inc Ordinary Shares | 3.61% |
| 8 | SYY | Sysco Corp | 3.58% |
| 9 | BMY | Bristol-Myers Squibb Co | 3.51% |
| 10 | DOC | Healthpeak Properties Inc | 3.26% |
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in dividend paying common stocks. As part of its strategy, the fund, in order to generate additional portfolio income, will selectively write (i.e., sell) covered call options, on a target range of between 25-40% of the underlying equity securities owned by the fund (although the fundamental “value” features of the fund’s approach to portfolio security selection stated above take precedence over option writing potential in that process).
Inception Date: 2024-03-06